PABIR3: A Protein with Potential as A Drug Target, Biomarker and Diagnostic Agent

Target Name: PABIR3

NCBI ID: G159091

PABIR3

PABIR3: A Protein with Potential as A Drug Target, Biomarker and Diagnostic Agent

PABIR3 (PABIR3 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the PABIR family of proteins, which are known for their role in the regulation of inflammation and fibrosis.

Recent studies have identified PABIR3 as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because PABIR3 has been shown to play a role in the development and progression of these conditions.

One of the reasons for the potential of PABIR3 as a drug target is its involvement in the regulation of inflammation. PABIR3 has been shown to play a role in the regulation of inflammatory responses, both in the brain and in other tissues. Studies have shown that PABIR3 helps to reduce the amount of inflammation caused by bacteria and other irritants, and that it also helps to protect against the development of chronic inflammatory diseases.

In addition to its role in inflammation, PABIR3 has also been shown to be involved in the regulation of fibrosis. Fibrosis is the process by which tissues become thickened and fibrotic, leading to the development of various diseases, including cancer. Studies have shown that PABIR3 helps to regulate the growth and spread of fibrotic tissues, and that it can be used as a potential therapeutic agent for treating fibrosive diseases.

Another potential use of PABIR3 as a drug target is its role in the regulation of cell death. Cell death, also known as apoptosis, is a natural process that helps to remove damaged or dysfunctional cells from the body. However, in the case of diseases such as cancer, apoptosis can become abnormal and lead to the development of cancer cells. Studies have shown that PABIR3 helps to regulate cell death, both in normal tissues and in cancer cells. This may make PABIR3 an attractive target for therapies aimed at treating cancer.

In addition to its potential as a drug target or biomarker, PABIR3 has also been shown to have potential as a diagnostic agent. Studies have shown that PABIR3 is expressed in a variety of tissues and that it is highly stable in the presence of various diseases, including cancer. This may make PABIR3 an attractive candidate for use as a diagnostic agent for a variety of diseases.

Overall, PABIR3 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its involvement in the regulation of inflammation, fibrosis, and cell death makes it an attractive candidate for these roles, and its potential as a diagnostic agent may also make it a valuable tool in the fight against these diseases. Further research is needed to fully understand the role of PABIR3 in these processes and to develop safe and effective therapies based on it.

Protein Name: PABIR Family Member 3

The "PABIR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PABIR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets